2m 2m 2m 2m 2m 2m 2m
DELCATH SYS (DCTH)
NASDAQ
$15.91-$0.005 (-0.03%)
Price as of Sep 11, 2026 7:30 PM EDT- $552.1MMarket Cap
- 46.77%1-Year Change
- Medical DevicesIndustry
DELCATH SYS (DCTH)
$15.91-$0.005 (-0.03%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
ROSALIND ADVISORS, INC. | 9.56% | 3.3M | 0 (0.00%) | Jun 30, 2026 |
BLACKROCK, INC. | 7.84% | 2.7M | +922,336 (+34.07%) | Jun 30, 2026 |
VANGUARD GROUP INC | 4.84% | 1.7M | +14,929 (+0.89%) | Dec 31, 2025 |
VANGUARD CAPITAL MANAGEMENT LLC | 3.54% | 1.2M | -108,041 (-8.85%) | Jun 30, 2026 |
PROPEL BIO MANAGEMENT, LLC | 2.52% | 871,460 | -108,238 (-12.42%) | Jun 30, 2026 |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.35% | 812,561 | -545 (-0.07%) | Jun 30, 2025 |
GEODE CAPITAL MANAGEMENT, LLC | 2.12% | 733,115 | +41,084 (+5.60%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.46% | 1.2M | -101,642 (-8.51%) | Jun 30, 2026 |
iSHARES TRUST | 3.38% | 1.2M | +75,122 (+6.44%) | Jun 30, 2026 |
OBERWEIS FUNDS | 1.21% | 419,400 | 0 (0.00%) | Jun 30, 2026 |
Invesco Exchange-Traded Fund Trust II | 0.93% | 320,418 | 0 (0.00%) | Apr 30, 2026 |
Simplify Exchange Traded Funds | 0.77% | 264,770 | +3,644 (+1.38%) | Jun 30, 2026 |
FIDELITY CONCORD STREET TRUST | 0.74% | 253,930 | -924 (-0.36%) | May 31, 2026 |
North Square Investments Trust | 0.58% | 201,092 | +124,613 (+61.97%) | May 31, 2026 |
Current Ownership Distribution
- Institutions171.7M (79.07%)
- Mutual Funds37.1M (17.11%)
- Insiders8.3M (3.83%)
- Other0 (0.00%)
Insider Transactions
- 3.83% (8.3M)Current InsiderOwnership (%, shares)
- 3Number of InsiderBuying (last 12 months)
- $6.4MAmount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Pennell Sandra Chief Financial Officer | Buy | Mar 06, 2026 | $50,018.32 | 5,533 | $9.04 | 77,018 |
MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Buy | Mar 02, 2026 | $100,309.44 | 11,200 | $8.96 | 342,034 |
Pennell Sandra Chief Financial Officer | Award | Feb 17, 2026 | $0.00 | 56,500 | $0.00 | 56,500 |
Hoffman David L. GEN'L COUNSEL, CCO & SECY | Award | Feb 17, 2026 | $0.00 | 56,500 | $0.00 | 56,500 |
Vukovic Vojo CHIEF MEDICAL OFFICER | Award | Feb 17, 2026 | $0.00 | 56,500 | $0.00 | 56,500 |
Rook Martha S. CHIEF OPERATING OFFICER | Award | Feb 17, 2026 | $0.00 | 56,500 | $0.00 | 56,500 |
MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Award | Feb 17, 2026 | $0.00 | 195,000 | $0.00 | 195,000 |
Hoffman David L. GEN'L COUNSEL, CCO & SECY | Award | Feb 17, 2026 | $0.00 | 28,250 | $0.00 | 28,250 |
Vukovic Vojo CHIEF MEDICAL OFFICER | Award | Feb 17, 2026 | $0.00 | 28,250 | $0.00 | 28,250 |
Muir Kevin GM INTERVENTIONAL ONCOLOGY | Award | Feb 17, 2026 | $0.00 | 56,500 | $0.00 | 56,500 |
Pennell Sandra Chief Financial Officer | Award | Feb 17, 2026 | $0.00 | 28,250 | $0.00 | 28,250 |
Rook Martha S. CHIEF OPERATING OFFICER | Award | Feb 17, 2026 | $0.00 | 28,250 | $0.00 | 28,250 |
MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Award | Feb 17, 2026 | $0.00 | 97,500 | $0.00 | 97,500 |
Muir Kevin GM INTERVENTIONAL ONCOLOGY | Award | Feb 17, 2026 | $0.00 | 28,250 | $0.00 | 28,250 |
Sylvester John Richard | Buy | Nov 21, 2025 | $38,991.54 | 4,386 | $8.89 | 14,936 |
MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Buy | Nov 11, 2025 | $98,049.00 | 11,500 | $8.53 | 330,834 |
Vukovic Vojo CHIEF MEDICAL OFFICER | Exempt | Jun 12, 2025 | $0.00 | 42,000 | $0.00 | 58,500 |
Vukovic Vojo CHIEF MEDICAL OFFICER | Exempt | Jun 12, 2025 | $200,760.00 | 42,000 | $4.78 | 168,882 |
SALAMON STEVEN A J | In The Money | May 05, 2025 | $4.0M | 400,000 | $10.00 | 3.4M |
Rosalind Advisors, Inc. | In The Money | May 05, 2025 | $4.0M | 400,000 | $10.00 | 3.4M |
Aharon Gil | In The Money | May 05, 2025 | $4.0M | 400,000 | $10.00 | 3.4M |
Rook Martha S. CHIEF OPERATING OFFICER | Award | Feb 07, 2025 | $0.00 | 113,000 | $0.00 | 113,000 |
Muir Kevin GM INTERVENTIONAL ONCOLOGY | Award | Feb 07, 2025 | $0.00 | 113,000 | $0.00 | 113,000 |
Pennell Sandra Chief Financial Officer | Award | Feb 07, 2025 | $0.00 | 113,000 | $0.00 | 113,000 |
MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Award | Feb 07, 2025 | $0.00 | 390,000 | $0.00 | 390,000 |
Vukovic Vojo CHIEF MEDICAL OFFICER | Award | Feb 07, 2025 | $0.00 | 113,000 | $0.00 | 113,000 |
Hoffman David L. GEN'L COUNSEL, CCO & SECY | Award | Feb 07, 2025 | $0.00 | 113,000 | $0.00 | 113,000 |
Rosalind Advisors, Inc. | Exempt | Dec 24, 2024 | $6.0M | 603,954 | $9.99 | 1.3M |
Rosalind Advisors, Inc. | Conversion | Dec 24, 2024 | $2.5M | 250,000 | $10.00 | 3.0M |
Rosalind Advisors, Inc. | Exempt | Oct 30, 2024 | $500,000.00 | 500 | $1,000.00 | 0 |